MECHANISM OF ACTION
The Wolverine Stack puts BPC-157 and TB-500 together in a single formulation so you get both working at the same time. BPC-157 handles the local work: growing new blood vessels into the injury site, protecting the gut lining, and kicking off repair in tendons and ligaments. TB-500 adds broader coverage: it sends repair signals throughout the body, calls in specialised repair cells, and damps down inflammation system-wide. The idea is that BPC-157's local vascular repair and TB-500's body-wide cell migration create a more complete recovery environment together than either does alone. Available in vial, pen, and nasal spray formats.
RESEARCH APPLICATIONS
- Comprehensive tendon, ligament, and muscle injury recovery
- Post-surgical tissue repair research
- Systemic + local recovery model (TB-500 systemic + BPC-157 local)
- GI repair with systemic anti-inflammatory support
- Athletic recovery and soft tissue research
RESEARCH HIGHLIGHTS
Synergistic Mechanism Evidence
Independent studies on each component show complementary mechanisms - TB-500 mobilises progenitor cells systemically while BPC-157 creates the angiogenic scaffold for integration at the injury site.
Ref: Multiple preclinical studies (see BPC-157 and TB-500 individual pages)
RESEARCH PROTOCOL NOTES
Chemical Identity
Storage & Stability
-20°C lyophilised. Reconstituted: 2–8°C, 21 days. Same storage rules as component peptides - the blend does not reduce stability.
Regulatory Status
Combined research compound. Same regulatory status as each component. Not WADA listed individually; TB-500 (Tβ4) is WADA S2 prohibited.
Important - read before proceeding
This page is a summary of published scientific literature about a molecule. It is provided for research and educational purposes only. Nothing on this page is medical advice, a diagnosis, a recommendation, a prescription, or a claim that this compound treats, cures, prevents or improves any condition in humans. Research findings described here are observations reported by third-party researchers about the molecule - they are not statements about the product supplied by Bio Intelligence, and they should not be read as an expected outcome.
Compounds supplied are not registered medicines, have not been evaluated by SAHPRA, and are not for human consumption. No dosing, route of administration or usage guidance is provided by Bio Intelligence. If you have a health concern, speak to a registered healthcare practitioner.